Skip to main content
Beta
Checking market hours
MarketsLoading authentic market snapshot...

GILD — Gilead Sciences, Inc

Unclassified · Common StockOpen Vantage View
Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search

GILDGilead Sciences, Inc Live data

$169.55▼ -1.32 (-0.8%)as of Nov 11, 2026, 6:08 PM UTC
Price chartUnavailable
Loading price history...

52-Week Range

Trailing twelve months

$116.88$176.58

1-Month Range

Month up 14.6%

$147.92$174.48

Daily Price Range

Day down -0.8%

$168.37$170.41

Volume

vs 6M avg

1M6M avg

Profile

Identity and capital structure

SectorUnclassified
IndustryCommon Stock
Market Cap$210.3B
Short % of Float—
Employees—
Sales$29,443M
Shares Outstanding1,240,338,614
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Gilead Sciences, Inc — Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspen….· via yahoo

Warnings

2 signals

Live
  • Debt/Equity elevated at 202.5
  • ROE below 5% (-22.4%)

Scores

0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)

Value
62
Growth
48
Quality
30
Sentiment
95
Insider Sent.
0
Piotroski F
8
Altman Z
5.0
Consensus rating unavailable — no analyst coverage on file for GILD.
Price targets unavailable — no 12-month targets on file for GILD.
Valuation Engine

DCF Intrinsic Valuation Model

Run an interactive 5-year Discounted Cash Flow valuation on GILD, calculate Margin of Safety, and stress-test WACC discount hurdles.

Open DCF Workstation
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 2 warnings surfacedNov 11, 2026, 6:08 PM UTC